⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30106045 | 0.81 | DGAT1 (0.31) | — | |
| SCHEMBL21751870 | 0.81 | DGAT1 (0.34) | — | |
| SCHEMBL20767569 | 0.80 | KDM4E (0.36) | — | |
| SCHEMBL30106000 | 0.80 | KDM4E (0.36) | — | |
| SCHEMBL30106030 | 0.80 | CA2 (0.31) | — | |
| SCHEMBL28440805 | 0.80 | DGAT1 (0.33) | — | |
| SCHEMBL23908133 | 0.71 | — | — | |
| SCHEMBL30106048 | 0.71 | — | — | |
| SCHEMBL30106008 | 0.69 | DGAT1 (0.32) | — | |
| SCHEMBL20767572 | 0.69 | DGAT1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250179090-A1 | CONDENSED HETEROCYCLIC DERIVATIVES AS BCL-2 INHIBITORS FOR THE TREATMENT OF NEOPLASTIC DISEASES | NEWAVE PHARMACEUTICAL INC. | 2025-06-05 | — | — | US | disclosed |